LianBio, founded, seeded and incubated by Perceptive Advisors, announced its launch on 11 August 2020 with a diverse arr...
An innovative, environmentally friendly treatment with no side effects has been made available to COVID-19 patients, inv...
Researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently conducted a ...
China-based Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures and...
Regulations, China Impact and Geopolitics were the top themes in 2020 for Japanese companies to reduce dependency on Chi...
ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd recently announced a clinical collaboration and excl...
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...
Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company based in the US and Shanghai-based Viva ...
US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...
Recently, Chinese company Gan & Lee Pharmaceuticals Co., Ltd. (Gan & Lee), has launched their first Phase 1 huma...
According to the Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown exc...
China based Viva Biotech Holdings and Schrödinger, Inc. in the US have announced a strategic collaboration to ...
The European Commission (EC) has approved Shanghai-based Henlius Biotech, Inc. and Accord Healthcare Limited (Accor...
Alzheimer's Association International Conference (AAIC), the largest and most influential international conference on de...
Shanghai Henlius Biotech, Inc. announced that Marketing Authorization Application (“MAA”) for HLX02 (trastuz...
Ping An Insurance (Group) Company of China, Ltd. is pleased to announce that agreements have been signed with ...
Chinese clinical trial and research firm Hangzhou Tigermed consulting is initiating fundraising of at least $1 billion i...
